propranolol has been researched along with Tachycardia, Supraventricular in 78 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Tachycardia, Supraventricular: A generic expression for any tachycardia that originates above the BUNDLE OF HIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of angioedema secondary to propranolol therapy in a patient with chronic hepatitis C virus (HCV) infection is reported." | 7.76 | Propranolol-induced angioedema in a patient with chronic hepatitis C virus infection. ( Artacho-Criado, S; Dorantes-Calderon, B; Grande-Santamaria, L; Márquez-Saavedra, E; Morillo-Verdugo, R; Romero-Gómez, M, 2010) |
| "We report a case of pulmonary fibrosis in an infant receiving amiodarone for treatment of intractable atrioventricular reentrant tachycardia secondary to Wolff-Parkinson-White syndrome." | 7.70 | Amiodarone induced pulmonary fibrosis in infancy. ( Bowers, PN; Fields, J; Nehgme, R; Rosenfeld, LE; Schwartz, D, 1998) |
| "Hypoglycemia is a known adverse effect of propranolol therapy, but little research has been done on the incidence and risk of hypoglycemia in treatment of SVT in infants with propranolol." | 5.91 | Assessing the Risk of Hypoglycemia Secondary to Propranolol Therapy for the Treatment of Supraventricular Tachycardia in Infants. ( Bugnitz, C; Flowers, R; Parker, N; Stolfi, A; Vickery, K, 2023) |
| "Accelerated idioventricular rhythm (AIVR) is a ventricular arrhythmia most commonly seen in adults with underlying cardiac disease." | 5.38 | Accelerated idioventricular rhythm associated with propranolol treatment in a child. ( Andiran, N; Aydin, H; Ceylan, Y; Gultekin, A; Koksoy, AY; Ozdemir, O, 2012) |
| "In the Beta Blocker Heart Attack Trial (BHAT), 3837 patients were randomized to propranolol (180-240 mg/day) or placebo 5-21 days after a documented myocardial infarction and were followed in a double blind manner for a mean period of 25 months." | 5.06 | Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group. ( Barker, A; Byington, RP; Peters, RW; Yusuf, S, 1990) |
| "Racemic sotalol is an effective Class III antiarrhythmic agent approved by the Food and Drug Administration for the treatment of documented life-threatening ventricular arrhythmias." | 4.78 | Sotalol: a breakthrough antiarrhythmic? ( McCollam, PL; Nappi, JM, 1993) |
| "A case of angioedema secondary to propranolol therapy in a patient with chronic hepatitis C virus (HCV) infection is reported." | 3.76 | Propranolol-induced angioedema in a patient with chronic hepatitis C virus infection. ( Artacho-Criado, S; Dorantes-Calderon, B; Grande-Santamaria, L; Márquez-Saavedra, E; Morillo-Verdugo, R; Romero-Gómez, M, 2010) |
| "Propranolol was given to 16 patients, with two successes and one partial success." | 3.76 | Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study. ( Cifarelli, A; Garcia, JM; Garson, A; Herre, J; Vetter, VL; Villain, E, 1990) |
| "We report a case of pulmonary fibrosis in an infant receiving amiodarone for treatment of intractable atrioventricular reentrant tachycardia secondary to Wolff-Parkinson-White syndrome." | 3.70 | Amiodarone induced pulmonary fibrosis in infancy. ( Bowers, PN; Fields, J; Nehgme, R; Rosenfeld, LE; Schwartz, D, 1998) |
| " Authors diagnosed a rare type of thyrotoxicosis-triiodothyronine toxicosis+, which was only manifested by long-lasting supraventricular tachycardia without clinical state impairment." | 3.68 | [Long-term supraventricular tachycardia in a patient with triiodothyronine toxicosis]. ( Moszczyński, P; Słowiński, S; Zabówka, M, 1990) |
| "The primary end point was recurrence of SVT requiring medical intervention." | 2.77 | The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants. ( Anderson, CC; Bar-Cohen, Y; Batra, AS; Blaufox, AD; Etheridge, SP; Fournier, A; Gibbs, KA; Kanter, RJ; Mackie, AS; McCrindle, BW; Potts, JE; Reed, JH; Ro, PS; Ross, BA; Sanatani, S; Saul, JP; Singh, HR; Stephenson, EA; Tisma-Dupanovic, S; Wong, KK, 2012) |
| "Diltiazem was ineffective in preventing SVT, the incidence being exactly the same as in the control group (35%)." | 2.68 | Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. ( Babin-Ebell, J; Elert, O; Keith, PR, 1996) |
| " Once a day nadolol is a safe and effective agent in the management of supraventricular tachycardia in children." | 2.67 | Efficacy and safety of intravenous and oral nadolol for supraventricular tachycardia in children. ( Chidambaram, B; Mehta, AV, 1992) |
| " Drug-related adverse effects necessitating discontinuation of the drug occurred in four receiving low doses (2." | 2.67 | Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. ( Adan, AJ; Defauw, JA; Ernst, SM; Kingma, JH; Koomen, EM; Suttorp, MJ; Tjon Joe Gin, RM; van Hemel, NM, 1990) |
| "Holter monitoring revealed ectopic atrial tachycardia during tachyarrhythmia and occasional sinus pauses with junctional escape beats." | 2.61 | Severe congenital RYR1-associated myopathy complicated with atrial tachycardia and sinus node dysfunction: a case report. ( Abe, Y; Hayakawa, I; Kubota, M; Ono, H, 2019) |
| "Digoxin was the initial treatment in 84." | 2.38 | [Supraventricular paroxysmal tachycardia without congenital heart disease: clinical, therapeutic aspects and course in 65 children]. ( Cabezuelo Huerta, G; Frontera Izquierdo, P, 1991) |
| "Propranolol was the most frequently used first-line AM (92% and 95%)." | 1.91 | Multicenter cohort study on duration of antiarrhythmic medication for supraventricular tachycardia in infants. ( Arola, A; Happonen, JM; Hiippala, A; Leino, T; Leskinen, M; Linnanmäki, A; Mecklin, M; Poutanen, T; Ruotsalainen, H, 2023) |
| "Hypoglycemia is a known adverse effect of propranolol therapy, but little research has been done on the incidence and risk of hypoglycemia in treatment of SVT in infants with propranolol." | 1.91 | Assessing the Risk of Hypoglycemia Secondary to Propranolol Therapy for the Treatment of Supraventricular Tachycardia in Infants. ( Bugnitz, C; Flowers, R; Parker, N; Stolfi, A; Vickery, K, 2023) |
| "On-treatment recurrence was observed in 30." | 1.56 | Experience using propranolol for the management of supraventricular tachycardia in patients younger than 1 year. ( Abello, MS; Díaz, CJ; Doiny, DG; Falconi, EC; Majdalani, MG; Moltedo, JM; Nicastro, ES, 2020) |
| "Propranolol therapy was considered successful when patients were initiated and discharged on monotherapy, without documented recurrence of arrhythmia or requiring additional antiarrhythmic medication." | 1.42 | Efficacy and safety of high-dose propranolol for the management of infant supraventricular tachyarrhythmias. ( Barton, AL; Kim, JJ; Miyake, C; Moffett, BS; Valdes, SO, 2015) |
| "Digoxin was associated with fewer episodes of supraventricular tachycardia recurrence but more frequent hypotension in hospitalized infants relative to propranolol." | 1.40 | Comparative effectiveness of digoxin and propranolol for supraventricular tachycardia in infants. ( Chu, PY; Clark, RH; Hill, KD; Hornik, CP; Li, JS; Smith, PB, 2014) |
| "Adenosine has been well studied as a mainstay treatment, but the methods of adenosine administration have not been very well delineated." | 1.38 | Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia. ( Goodman, IS; Lu, CJ, 2012) |
| "Accelerated idioventricular rhythm (AIVR) is a ventricular arrhythmia most commonly seen in adults with underlying cardiac disease." | 1.38 | Accelerated idioventricular rhythm associated with propranolol treatment in a child. ( Andiran, N; Aydin, H; Ceylan, Y; Gultekin, A; Koksoy, AY; Ozdemir, O, 2012) |
| "Flecainide for the treatment of supraventricular tachycardia (SVT) in newborns is still controversial because of its potentially severe proarrhythmic effects." | 1.35 | Flecainide as first-line treatment for supraventricular tachycardia in newborns. ( Bonanomi, C; Centola, M; Colli, AM; Danzi, GB; Ferlini, M; Galli, MA; Ravaglia, R; Salice, P; Salvini, L, 2009) |
| "Recurrence was defined as documented SVT at >1 year of age." | 1.32 | Frequency of recurrence among infants with supraventricular tachycardia and comparison of recurrence rates among those with and without preexcitation and among those with and without response to digoxin and/or propranolol therapy. ( Fenrich, AL; Friedman, RA; Kertesz, NJ; Smith, EO; Snyder, CS; Tortoriello, TA, 2003) |
| "Verapamil was used in one infant with AV node reentry tachycardia." | 1.29 | Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. ( Saul, JP; Walsh, EP; Weindling, SN, 1996) |
| "Supraventricular tachycardia is relatively common in pregnancy, and is related to the normal physiologic changes of the cardiovascular system in the gravid state." | 1.28 | Supraventricular tachycardia resistant to treatment in a pregnant woman. ( Hulkower, S; Kostic, B; Treakle, K, 1992) |
| " Prazosin produced a dose-response decrease in EAD amplitude and reduced the prevalence of VT." | 1.28 | Alpha-adrenoceptor stimulation and blockade modulates cesium-induced early afterdepolarizations and ventricular tachyarrhythmias in dogs. ( Ben-David, J; Zipes, DP, 1990) |
| "Two cases of dilated cardiomyopathy with incessant supraventricular tachycardia were treated with beta-blockade." | 1.28 | Two cases of dilated cardiomyopathy associated with incessant supraventricular tachycardia who showed a favorable response to beta-blockade. ( Ishii, M; Ishikawa, T; Kimura, K; Kobayashi, K; Kuji, N; Sano, T; Sugimoto, K; Yoshimura, H, 1990) |
| " These results suggest that propranolol in the above dosage does not significantly reduce the incidence of supraventricular tachyarrhythmias after myocardial revascularisation." | 1.27 | Does low-dose propranolol reduce the incidence of supraventricular tachyarrhythmias following myocardial revascularisation? A clinical study. ( Bain, WH; Nashef, SA; Shafei, H; Turner, MA, 1988) |
| "A case of severe nonimmune hydrops fetalis caused by supraventricular tachycardia is presented." | 1.27 | Insufficient transplacental digoxin transfer in severe hydrops fetalis. ( Granat, M; Younis, JS, 1987) |
| "Disopyramide was less effective than previously reported." | 1.27 | Effects of four antiarrhythmic drugs on the induction and termination of paroxysmal supraventricular tachycardia. ( Ishinaga, T; Komatsu, C; Tateishi, O; Tokuhisa, Y; Yoshimura, S, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (24.36) | 18.7374 |
| 1990's | 29 (37.18) | 18.2507 |
| 2000's | 8 (10.26) | 29.6817 |
| 2010's | 17 (21.79) | 24.3611 |
| 2020's | 5 (6.41) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, JA | 1 |
| Stephens, SB | 1 |
| Kertesz, NJ | 2 |
| Evans, DL | 1 |
| Kim, JJ | 3 |
| Howard, TS | 1 |
| Pham, TD | 1 |
| Valdés, SO | 3 |
| de la Uz, CM | 1 |
| Raymond, TT | 1 |
| Morris, SA | 1 |
| Miyake, CY | 2 |
| Mecklin, M | 1 |
| Linnanmäki, A | 1 |
| Hiippala, A | 1 |
| Leino, T | 1 |
| Arola, A | 1 |
| Leskinen, M | 1 |
| Ruotsalainen, H | 1 |
| Happonen, JM | 1 |
| Poutanen, T | 1 |
| Parker, N | 1 |
| Flowers, R | 1 |
| Vickery, K | 1 |
| Stolfi, A | 1 |
| Bugnitz, C | 1 |
| Ciriello, GD | 1 |
| Colonna, D | 1 |
| Papaccioli, G | 1 |
| Correra, A | 1 |
| Romeo, E | 1 |
| Palladino, MT | 1 |
| Cioppa, ND | 1 |
| Russo, MG | 1 |
| Sarubbi, B | 1 |
| Hayakawa, I | 1 |
| Abe, Y | 1 |
| Ono, H | 1 |
| Kubota, M | 1 |
| Nicastro, ES | 1 |
| Majdalani, MG | 1 |
| Abello, MS | 1 |
| Doiny, DG | 1 |
| Falconi, EC | 1 |
| Díaz, CJ | 1 |
| Moltedo, JM | 1 |
| Bolin, EH | 1 |
| Lang, SM | 1 |
| Tang, X | 1 |
| Collins, RT | 1 |
| Bravo-Valenzuela, NJ | 1 |
| Peixoto, AB | 1 |
| Araujo Júnior, E | 1 |
| Tonni, G | 1 |
| Hornik, CP | 1 |
| Chu, PY | 1 |
| Li, JS | 1 |
| Clark, RH | 1 |
| Smith, PB | 1 |
| Hill, KD | 1 |
| Moffett, BS | 2 |
| Lupo, PJ | 1 |
| delaUz, CM | 1 |
| Decker, JA | 1 |
| Barton, AL | 1 |
| Miyake, C | 1 |
| Spearman, AD | 1 |
| Williams, P | 1 |
| Pfammatter, JP | 1 |
| Ergül, Y | 1 |
| Özyılmaz, İ | 1 |
| Saygı, M | 1 |
| Tola, HT | 1 |
| Akdeniz, C | 1 |
| Tuzcu, V | 1 |
| Nikolla, DA | 1 |
| Carlson, JN | 1 |
| Gardiner, M | 1 |
| Ruttan, TK | 1 |
| Kienstra, AJ | 1 |
| Wilkinson, M | 1 |
| Mine, T | 1 |
| Shimizu, H | 1 |
| Hiromoto, K | 1 |
| Furukawa, Y | 1 |
| Kanemori, T | 1 |
| Nakamura, H | 1 |
| Masuyama, T | 1 |
| Ohyanagi, M | 1 |
| Ferlini, M | 1 |
| Colli, AM | 1 |
| Bonanomi, C | 1 |
| Salvini, L | 1 |
| Galli, MA | 1 |
| Salice, P | 1 |
| Ravaglia, R | 1 |
| Centola, M | 1 |
| Danzi, GB | 1 |
| Márquez-Saavedra, E | 1 |
| Artacho-Criado, S | 1 |
| Morillo-Verdugo, R | 1 |
| Grande-Santamaria, L | 1 |
| Dorantes-Calderon, B | 1 |
| Romero-Gómez, M | 1 |
| De Rita, F | 1 |
| Barozzi, L | 1 |
| Franchi, G | 1 |
| Faggian, G | 1 |
| Mazzucco, A | 1 |
| Luciani, GB | 1 |
| Goodman, IS | 1 |
| Lu, CJ | 1 |
| Ozdemir, O | 1 |
| Ceylan, Y | 1 |
| Koksoy, AY | 1 |
| Aydin, H | 1 |
| Gultekin, A | 1 |
| Andiran, N | 1 |
| Sanatani, S | 1 |
| Potts, JE | 1 |
| Reed, JH | 1 |
| Saul, JP | 2 |
| Stephenson, EA | 1 |
| Gibbs, KA | 1 |
| Anderson, CC | 1 |
| Mackie, AS | 1 |
| Ro, PS | 1 |
| Tisma-Dupanovic, S | 1 |
| Kanter, RJ | 1 |
| Batra, AS | 1 |
| Fournier, A | 1 |
| Blaufox, AD | 1 |
| Singh, HR | 1 |
| Ross, BA | 1 |
| Wong, KK | 1 |
| Bar-Cohen, Y | 1 |
| McCrindle, BW | 1 |
| Etheridge, SP | 1 |
| Perry, JC | 1 |
| Doherty, G | 1 |
| Bali, S | 1 |
| Casey, F | 1 |
| Tortoriello, TA | 1 |
| Snyder, CS | 1 |
| Smith, EO | 1 |
| Fenrich, AL | 1 |
| Friedman, RA | 1 |
| Kurbanov, RD | 1 |
| Azimova, NA | 1 |
| Kiakbaev, GK | 1 |
| Abdullaev, TA | 1 |
| Asriiants, LS | 1 |
| Zakirov, NU | 1 |
| Avezov, DK | 1 |
| Faĭzullaev, BP | 1 |
| Klocke, G | 1 |
| Wisser, J | 1 |
| Riesselmann, A | 1 |
| Knitza, R | 1 |
| Hepp, H | 1 |
| Nappi, JM | 1 |
| McCollam, PL | 1 |
| Weindling, SN | 1 |
| Walsh, EP | 1 |
| Gulati, SK | 1 |
| Kabra, SK | 1 |
| Kothari, SS | 1 |
| Alboni, P | 2 |
| Fucà, G | 2 |
| Paparella, N | 2 |
| Scarfò, S | 1 |
| Pirani, R | 1 |
| Babin-Ebell, J | 1 |
| Keith, PR | 1 |
| Elert, O | 1 |
| Lemler, MS | 1 |
| Schaffer, MS | 1 |
| Yu, WC | 1 |
| Chen, SA | 1 |
| Lee, SH | 1 |
| Tai, CT | 1 |
| Feng, AN | 1 |
| Kuo, BI | 1 |
| Ding, YA | 1 |
| Chang, MS | 1 |
| Bowers, PN | 1 |
| Fields, J | 1 |
| Schwartz, D | 1 |
| Rosenfeld, LE | 1 |
| Nehgme, R | 1 |
| Cheng, TO | 1 |
| Kou, WH | 1 |
| Man, KC | 1 |
| Goyal, R | 1 |
| Strickberger, SA | 1 |
| Morady, F | 2 |
| Barr, FE | 1 |
| Patel, NR | 1 |
| Newth, CJ | 1 |
| Tomasi, C | 1 |
| Menozzi, C | 1 |
| Bottoni, N | 1 |
| Brignole, M | 1 |
| Cappato, R | 1 |
| Bert, AA | 1 |
| Reinert, SE | 1 |
| Singh, AK | 1 |
| Tahapary, GJ | 1 |
| Suttorp, MJ | 2 |
| Treakle, K | 1 |
| Kostic, B | 1 |
| Hulkower, S | 1 |
| Mehta, AV | 1 |
| Chidambaram, B | 1 |
| Battiste, CE | 1 |
| Neff, TW | 1 |
| Evans, JF | 1 |
| Cline, BW | 1 |
| Gupta, A | 1 |
| Lennmarken, C | 1 |
| Lemming, D | 1 |
| Lindqvist, J | 1 |
| Cabezuelo Huerta, G | 1 |
| Frontera Izquierdo, P | 1 |
| Frolov, AI | 1 |
| Bobrov, VA | 1 |
| Mitchenko, EI | 1 |
| Chervonopiskaia, EM | 1 |
| Galichanskiĭ, IV | 1 |
| Delikatnaia, NV | 1 |
| Gil, R | 1 |
| Arnaldo, F | 1 |
| García Escudero, A | 1 |
| Tajer, C | 1 |
| González Zuelgaray, J | 1 |
| Bertolasi, CA | 1 |
| Langberg, JJ | 1 |
| Calkins, H | 1 |
| Sousa, J | 1 |
| el-Atassi, R | 1 |
| Ben-David, J | 1 |
| Zipes, DP | 1 |
| Binder, LS | 1 |
| Boeche, R | 1 |
| Atkinson, D | 1 |
| Yoshimura, H | 1 |
| Ishikawa, T | 1 |
| Kuji, N | 1 |
| Sugimoto, K | 1 |
| Kimura, K | 1 |
| Sano, T | 1 |
| Kobayashi, K | 1 |
| Ishii, M | 1 |
| Kováts-Szabó, E | 1 |
| Horváth, I | 1 |
| Nagy, M | 1 |
| Kádár, K | 1 |
| Villain, E | 1 |
| Vetter, VL | 1 |
| Garcia, JM | 1 |
| Herre, J | 1 |
| Cifarelli, A | 1 |
| Garson, A | 1 |
| Kingma, JH | 1 |
| Tjon Joe Gin, RM | 1 |
| van Hemel, NM | 1 |
| Koomen, EM | 1 |
| Defauw, JA | 1 |
| Adan, AJ | 1 |
| Ernst, SM | 1 |
| Słowiński, S | 1 |
| Moszczyński, P | 1 |
| Zabówka, M | 1 |
| Peters, RW | 1 |
| Byington, RP | 1 |
| Barker, A | 1 |
| Yusuf, S | 1 |
| Popov, SV | 1 |
| Chekhov, AM | 1 |
| Pekarskiĭ, VV | 1 |
| Gimrikh, EO | 1 |
| Savenkov, GG | 1 |
| Huikuri, HV | 1 |
| Cox, M | 1 |
| Interian, A | 1 |
| Kessler, KM | 1 |
| Glicksman, F | 1 |
| Castellanos, A | 1 |
| Myerburg, RJ | 1 |
| Kao, W | 1 |
| Gheorghiade, M | 1 |
| Aronow, WS | 1 |
| Sarno, AP | 1 |
| Masaki, DI | 1 |
| Platt, LD | 1 |
| Paul, RH | 1 |
| Shafei, H | 1 |
| Nashef, SA | 1 |
| Turner, MA | 1 |
| Bain, WH | 1 |
| Martinussen, HJ | 1 |
| Lolk, A | 1 |
| Szczepanski, C | 1 |
| Alstrup, P | 1 |
| Casciani, M | 1 |
| Podestà, M | 1 |
| Carolis, S | 1 |
| Bargellini, F | 1 |
| Anticoli Borza, S | 1 |
| Tsuchioka, Y | 1 |
| Matsumoto, K | 1 |
| Fujii, H | 1 |
| Masaoka, S | 1 |
| Yuasa, A | 1 |
| Tateishi, H | 1 |
| Matsuura, H | 1 |
| Sato, H | 1 |
| Kajiyama, G | 1 |
| Zatuchni, J | 1 |
| Kuck, KH | 1 |
| Nguyen, NX | 1 |
| Yang, PT | 1 |
| Huycke, EC | 1 |
| Keung, EC | 1 |
| Deedwania, P | 1 |
| Sung, RJ | 1 |
| McBride, JW | 1 |
| McCoy, HG | 1 |
| Goldenberg, IF | 1 |
| Younis, JS | 1 |
| Granat, M | 1 |
| Chan, KY | 1 |
| Yip, WC | 1 |
| Ng, MP | 1 |
| Tay, JS | 1 |
| Wong, HB | 1 |
| Tan, CL | 1 |
| Prochaczek, F | 1 |
| Becker, A | 1 |
| Matuszewska, J | 1 |
| Komatsu, C | 1 |
| Ishinaga, T | 1 |
| Tateishi, O | 1 |
| Tokuhisa, Y | 1 |
| Yoshimura, S | 1 |
| Somani, P | 1 |
| Bachand, RT | 1 |
| Frieden, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular Tachycardia[NCT00390546] | Phase 3 | 72 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| Double Blind, Randomised, Placebo-controlled Study of Propranolol in Infantile Capillary Hemangiomas[NCT00744185] | Phase 2/Phase 3 | 14 participants (Actual) | Interventional | 2008-10-31 | Terminated (stopped due to Study halted prematurely due to some difficulties in recruitment of patients) | ||
| [NCT00000492] | Phase 3 | 0 participants | Interventional | 1977-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
In relation to the study drugs (NCT00390546)
Timeframe: 12 months
| Intervention | participants (Number) |
|---|---|
| Digoxin | 0 |
| Propranolol | 0 |
(NCT00390546)
Timeframe: 6 months or until study endpoints were reached
| Intervention | percentage of participants (Number) |
|---|---|
| Digoxin | 12 |
| Propranolol | 18 |
Infants treated with propranolol or digoxin (NCT00390546)
Timeframe: up to 110 days of treatment
| Intervention | participants (Number) |
|---|---|
| Digoxin | 6 |
| Propranolol | 12 |
6 reviews available for propranolol and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Severe congenital RYR1-associated myopathy complicated with atrial tachycardia and sinus node dysfunction: a case report.
Topics: Electrocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Genetic Predisposit | 2019 |
Sotalol: a breakthrough antiarrhythmic?
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrophysiology; | 1993 |
Termination of paroxysmal supraventricular tachycardia with a nasogastric tube--a case report.
Topics: Adult; Humans; Intubation, Gastrointestinal; Male; Metoprolol; Propranolol; Tachycardia, Paroxysmal; | 1991 |
[Supraventricular paroxysmal tachycardia without congenital heart disease: clinical, therapeutic aspects and course in 65 children].
Topics: Amiodarone; Child; Child, Preschool; Digoxin; Female; Humans; Male; Propranolol; Tachycardia, Paroxy | 1991 |
Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study.
Topics: Amiodarone; Bundle of His; Digoxin; Drug Therapy, Combination; Echocardiography; Humans; Infant; Mul | 1990 |
Management of supraventricular tachyarrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Bradycardia; Huma | 1989 |
13 trials available for propranolol and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Propranolol Versus Digoxin in the Neonate for Supraventricular Tachycardia (from the Pediatric Health Information System).
Topics: Anti-Arrhythmia Agents; Arkansas; Digoxin; Dose-Response Relationship, Drug; Female; Follow-Up Studi | 2017 |
The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants.
Topics: Anti-Arrhythmia Agents; Canada; Chi-Square Distribution; Digoxin; Double-Blind Method; Female; Human | 2012 |
[Thrombocyte aggregation in patients with cardiac arrhythmias and effect of anti-arrhythmia agents].
Topics: Aconitine; Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Heart Rate; Huma | 1993 |
Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting.
Topics: Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Coronary Artery Bypass; Diltiazem; Dose-Res | 1996 |
Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Electroph | 1998 |
Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Anti-Arrhythmia Agents; Diltiazem; D | 2001 |
A beta-blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery.
Topics: Adrenergic beta-Antagonists; Aged; Cardiotonic Agents; Coronary Artery Bypass; Digoxin; Female; Huma | 2001 |
Efficacy and safety of intravenous and oral nadolol for supraventricular tachycardia in children.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combinatio | 1992 |
[Treatment of paroxysmal supraventricular tachycardia with a single oral doses of diltiazem and propranolol].
Topics: Administration, Oral; Adult; Diltiazem; Drug Combinations; Electrophysiology; Female; Heart Rate; Hu | 1991 |
Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study.
Topics: Amiodarone; Bundle of His; Digoxin; Drug Therapy, Combination; Echocardiography; Humans; Infant; Mul | 1990 |
Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations.
Topics: Administration, Oral; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Propranolol; Prospe | 1990 |
Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group.
Topics: Death, Sudden; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardi | 1990 |
Supraventricular tachyarrhythmias after coronary bypass surgery--a double blind randomized trial of prophylactic low dose propranolol.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Coronary Artery Bypass; Double-Blind Method; | 1988 |
60 other studies available for propranolol and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Clinical Predictors of Recurrent Supraventricular Tachycardia in Infancy.
Topics: Anti-Arrhythmia Agents; Humans; Infant; Propranolol; Prospective Studies; Retrospective Studies; Tac | 2022 |
Multicenter cohort study on duration of antiarrhythmic medication for supraventricular tachycardia in infants.
Topics: Anti-Arrhythmia Agents; Cohort Studies; Humans; Infant; Propranolol; Tachycardia, Atrioventricular N | 2023 |
Assessing the Risk of Hypoglycemia Secondary to Propranolol Therapy for the Treatment of Supraventricular Tachycardia in Infants.
Topics: Anti-Arrhythmia Agents; Humans; Hypoglycemia; Hypoglycemic Agents; Infant; Propranolol; Retrospectiv | 2023 |
Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Flecainide; Humans; Infant; Infant, Newborn; Propranolol; Tachyc | 2023 |
Experience using propranolol for the management of supraventricular tachycardia in patients younger than 1 year.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Electrocardiogr | 2020 |
Fetal supraventricular tachycardia at 12 weeks of gestation: diagnosis and follow up. A case report.
Topics: Adult; Anti-Arrhythmia Agents; Digoxin; Echocardiography; Female; Fetal Heart; Follow-Up Studies; Hu | 2019 |
Comparative effectiveness of digoxin and propranolol for supraventricular tachycardia in infants.
Topics: Anti-Arrhythmia Agents; Digoxin; Electrocardiography; Female; Humans; Infant; Infant, Newborn; Male; | 2014 |
Efficacy of digoxin in comparison with propranolol for treatment of infant supraventricular tachycardia: analysis of a large, national database.
Topics: Anti-Arrhythmia Agents; Databases as Topic; Digoxin; Female; Heart Defects, Congenital; Hospitalizat | 2015 |
Efficacy and safety of high-dose propranolol for the management of infant supraventricular tachyarrhythmias.
Topics: Anti-Arrhythmia Agents; Female; Humans; Infant; Infant, Newborn; Male; Propranolol; Recurrence; Retr | 2015 |
Supraventricular tachycardia in infancy and childhood.
Topics: Anti-Arrhythmia Agents; Humans; Infant, Newborn; Male; Prognosis; Propranolol; Tachycardia, Supraven | 2014 |
Treatment of a mostly self-limiting disease: keep it simple and safe.
Topics: Anti-Arrhythmia Agents; Digoxin; Female; Humans; Male; Propranolol; Tachycardia, Supraventricular | 2014 |
The use of flecainide in critical neonates and infants with incessant supraventricular tachycardias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Drug Therapy, Combination; Female; Flecainide | 2015 |
An unexpected cause of infantile dyspnea.
Topics: Cough; Dyspnea; Electrocardiography; Emergency Service, Hospital; Follow-Up Studies; Heart Failure; | 2017 |
Making the Quick Diagnosis: A Case of Neonatal Shock.
Topics: Acidosis; Acyclovir; Adenosine; Ampicillin; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antiviral | 2017 |
Beat-to-beat QT interval variability is primarily affected by the autonomic nervous system.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutter; Atropine; Autonomic Nervous Syst | 2008 |
Flecainide as first-line treatment for supraventricular tachycardia in newborns.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography, Ambula | 2009 |
Propranolol-induced angioedema in a patient with chronic hepatitis C virus infection.
Topics: Angioedema; Anti-Arrhythmia Agents; Female; Hepatitis C, Chronic; Humans; Middle Aged; Propranolol; | 2010 |
Rescue extracorporeal life support for acute verapamil and propranolol toxicity in a neonate.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Extracorporeal Membrane Oxygenation; Female; | 2011 |
Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia.
Topics: Adenosine; Amiodarone; Catheterization, Central Venous; Combined Modality Therapy; Drug Therapy, Com | 2012 |
Accelerated idioventricular rhythm associated with propranolol treatment in a child.
Topics: Accelerated Idioventricular Rhythm; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Child; Elec | 2012 |
Supraventricular tachycardia treatment efficacy in infants: on further review.
Topics: Anti-Arrhythmia Agents; Digoxin; Female; Humans; Male; Propranolol; Tachycardia, Supraventricular | 2012 |
Fetal hydrops due to supraventricular tachycardia--successful outcome in a difficult case.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Hydrops Fetalis; Pre | 2003 |
Frequency of recurrence among infants with supraventricular tachycardia and comparison of recurrence rates among those with and without preexcitation and among those with and without response to digoxin and/or propranolol therapy.
Topics: Age of Onset; Anti-Arrhythmia Agents; Digoxin; Female; Heart Defects, Congenital; Humans; Infant; In | 2003 |
[Therapy of fetal supraventricular tachycardia with esmolol (case report)].
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Female; Heart Rate, Fetal; Heart Sept | 1993 |
Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants.
Topics: Anti-Arrhythmia Agents; Catheter Ablation; Digoxin; Electrocardiography; Esophagus; Female; Follow-U | 1996 |
Propranolol in supraventricular tachycardia.
Topics: Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Electrocardiography; Humans; Infant, New | 1995 |
Effects of intravenous propranolol on cardiovascular hemodynamics during supraventricular tachycardia.
Topics: Adult; Cardiac Pacing, Artificial; Cardiovascular System; Drug Evaluation; Female; Hemodynamics; Hum | 1996 |
Neonatal supraventricular tachycardia: predictors of successful treatment withdrawal.
Topics: Anti-Arrhythmia Agents; Digoxin; Electrocardiography; Esophagus; Follow-Up Studies; Humans; Infant, | 1997 |
Amiodarone induced pulmonary fibrosis in infancy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography, Ambulatory; Fo | 1998 |
To use or not to use propranolol for prophylaxis of postthoracotomy arrhythmias.
Topics: Anti-Arrhythmia Agents; Humans; Postoperative Complications; Premedication; Propranolol; Tachycardia | 1999 |
Interaction between autonomic tone and the negative chronotropic effect of adenosine in humans.
Topics: Adenosine; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atropine; | 1999 |
The pharmacologic mechanism by which inhaled epinephrine reduces airway obstruction in respiratory syncytial virus-associated bronchiolitis.
Topics: Administration, Inhalation; Adrenergic Agonists; Adrenergic beta-Antagonists; Bronchiolitis, Viral; | 2000 |
Oral amiodarone and atrial fibrillation.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibril | 2001 |
Supraventricular tachycardia resistant to treatment in a pregnant woman.
Topics: Adult; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electric Countershock; Female; Flecainide; | 1992 |
In utero conversion of supraventricular tachycardia with digoxin and procainamide at 17 weeks' gestation.
Topics: Digoxin; Drug Therapy, Combination; Fetal Diseases; Gestational Age; Humans; Hydrops Fetalis; Infant | 1992 |
[The use of obzidan and metoprolol in patients with supraventricular systolic tachyarrhythmias].
Topics: Adolescent; Adult; Drug Evaluation; Female; Heart Conduction System; Heart Rate; Humans; Male; Metop | 1991 |
[Evaluation of the activity of the heart conduction system with special reference to the sinoatrial node automatism in patients with mitral valve prolapse syndrome].
Topics: Action Potentials; Adolescent; Adult; Ajmaline; Arrhythmia, Sinus; Atrial Function, Right; Atropine; | 1991 |
Noncapturing stimuli during the basic drive shorten ventricular refractoriness.
Topics: Adolescent; Adult; Aged; Atropine; Autonomic Nervous System; Cardiac Pacing, Artificial; Female; Hum | 1991 |
Alpha-adrenoceptor stimulation and blockade modulates cesium-induced early afterdepolarizations and ventricular tachyarrhythmias in dogs.
Topics: Adrenergic alpha-Antagonists; Animals; Cardiac Pacing, Artificial; Cesium; Dogs; Electrophysiology; | 1990 |
Evaluation and management of supraventricular tachycardia in children.
Topics: Anemia; Dehydration; Dopamine; Electric Countershock; Fluid Therapy; Heart Defects, Congenital; Huma | 1991 |
Two cases of dilated cardiomyopathy associated with incessant supraventricular tachycardia who showed a favorable response to beta-blockade.
Topics: Adult; Cardiomyopathy, Dilated; Humans; Male; Propranolol; Tachycardia, Supraventricular | 1990 |
[Intrauterine treatment of fetal tachycardia causing circulatory failure].
Topics: Digitalis Glycosides; Female; Fetal Diseases; Humans; Infant, Newborn; Pregnancy; Prenatal Diagnosis | 1990 |
[Long-term supraventricular tachycardia in a patient with triiodothyronine toxicosis].
Topics: Adult; Drug Therapy, Combination; Electrocardiography; Female; Humans; Methimazole; Propranolol; Tac | 1990 |
[Long-term treatment of ventricular arrhythmia caused by electrocardiographic long QT syndrome].
Topics: Arrhythmias, Cardiac; Atropine; Autonomic Nerve Block; Cardiac Complexes, Premature; Child; Combined | 1988 |
Efficacy of intravenous propranolol for suppression of inducibility of ventricular tachyarrhythmias with different electrophysiologic characteristics in coronary artery disease.
Topics: Aged; Coronary Disease; Electrophysiology; Female; Hemodynamics; Humans; Injections, Intravenous; Ma | 1989 |
A suggested new approach to supraventricular tachydysrhythmia after coronary bypass surgery.
Topics: Aged; Cardiac Pacing, Artificial; Combined Modality Therapy; Coronary Artery Bypass; Diltiazem; Elec | 1989 |
Fetal heart rate monitoring casebook. Peripartum management of fetal supraventricular tachycardia.
Topics: Digoxin; Drug Therapy, Combination; Female; Fetal Monitoring; Heart Rate, Fetal; Humans; Male; Pregn | 1989 |
Does low-dose propranolol reduce the incidence of supraventricular tachyarrhythmias following myocardial revascularisation? A clinical study.
Topics: Adrenergic beta-Antagonists; Drug Administration Schedule; Heart Rate; Humans; Hypotension; Myocardi | 1988 |
[Wolff-Parkinson-White syndrome and anesthesia].
Topics: Adult; Amiodarone; Anesthesia, General; Female; Flecainide; Humans; Propranolol; Tachycardia, Paroxy | 1987 |
Electrophysiological effects of propranolol in patients with sinus node dysfunction.
Topics: Arrhythmia, Sinus; Arrhythmias, Cardiac; Bradycardia; Electrocardiography; Electrophysiology; Female | 1988 |
Cardiovascular collapse after verapamil in supraventricular tachycardia.
Topics: Digoxin; Drug Interactions; Humans; Hypotension; Propranolol; Tachycardia, Supraventricular; Verapam | 1988 |
[Cardiac arrhythmia in hypertrophic cardiomyopathy. Diagnosis and therapy].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiac Pacing, Artificial; | 1987 |
Effects of beta-adrenergic stimulation on atrial latency and atrial vulnerability in patients with paroxysmal supraventricular tachycardia.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Drug Evaluation; Female; Heart Atria; Heart Conduction Syst | 1988 |
Supraventricular tachycardia treated with continuous infusions of propranolol.
Topics: Adult; Aged; Blood Pressure; Drug Evaluation; Female; Heart Rate; Humans; Infusions, Intravenous; In | 1988 |
Insufficient transplacental digoxin transfer in severe hydrops fetalis.
Topics: Adult; Digoxin; Edema; Female; Fetal Diseases; Humans; Maternal-Fetal Exchange; Pregnancy; Propranol | 1987 |
Efficacy of verapamil in the conversion of supraventricular tachycardia in Singapore children.
Topics: Child; Child, Preschool; Digoxin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infa | 1987 |
[Occurrence of latent retrograde atrioventricular conduction reaching the atrial conduction pathways in a patient with paroxysmal tachycardia of the re-entry type within the atrioventricular node after administration of propranolol].
Topics: Atrioventricular Node; Electrocardiography; Female; Heart Conduction System; Humans; Middle Aged; Pr | 1987 |
Effects of four antiarrhythmic drugs on the induction and termination of paroxysmal supraventricular tachycardia.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Female; Humans; Male; Middle Aged; Pr | 1986 |
Antiarrhythmic actions of propranolol in the dog heart-lung preparation.
Topics: Animals; Arrhythmias, Cardiac; Dogs; Female; Heart; Heart-Lung Machine; Male; Ouabain; Propranolol; | 1967 |
Propranolol as an antiarrhythmic agent.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Humans; Propranol | 1967 |